BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2741229
Number of visits today
1107
Number of downloads
2012819
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang C, Zheng X, Cao S. Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/6775496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou L, Cheng Q, Hu Y, Tan H, Li X, Wu S, Zhou T, Zhou J. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation. Front Oncol 2022;12:1030802. [PMID: 36620545 DOI: 10.3389/fonc.2022.1030802] [Reference Citation Analysis]
2 Li W, Yang G, Dong H, Zhu J, Liu T. A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1055785] [Reference Citation Analysis]
3 Li S, Man Q, Liu B. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.943945] [Reference Citation Analysis]
4 Zhong X, He X, Wang Y, Hu Z, Yu D, Huang H, Zhao S, Wei P, Li D, Zhang X. A Hypoxia-Related lncRNA Signature Correlates with Survival and Tumor Microenvironment in Colorectal Cancer. Journal of Immunology Research 2022;2022:1-23. [DOI: 10.1155/2022/9935705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345